miR-526b enhances glucose metabolism in breast cancer cells, an effect reversed by targeting the COX-2/EP4 pathway.

miR-526b 可增强乳腺癌细胞的葡萄糖代谢，而靶向 COX-2/EP4 通路可逆转这种作用